Modern Chinese Medicine Group Co., Ltd. (1643.HK)

HKD 0.34

(-6.94%)

Market Cap (In HKD)

201 Million

Revenue (In HKD)

344.07 Million

Net Income (In HKD)

48.79 Million

Avg. Volume

3.35 Million

Currency
HKD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.28-0.6
PE
16.75
EPS
0.02
Beta Value
0.379
ISIN
KYG6181B1068
CUSIP
-
CIK
-
Shares
600000000.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Ms. Hongli Zhang
Employee Count
-
Website
https://www.cdysjdyy.com
Ipo Date
2021-01-15
Details
Modern Chinese Medicine Group Co., Ltd., an investment holding company, produces and sells proprietary Chinese medicines for elderlies and aged-middle in the People's Republic of China. It offers therapeutics for the qi-deficiency and blood-statis, cardio-cerebrovascular, digestive and gastrointestinal, gynecological, respiratory system, and nervous system conditions. The company was founded in 1986 and is headquartered in Chengde, China. Modern Chinese Medicine Group Co., Ltd. is a subsidiary of Modern Biotechnology Group Holdings Co., Ltd.